Viyash Scientific Limited Files SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 08 Apr 2026, 03:05 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Viyash Scientific Limited filed its Q4FY26 compliance certificate under SEBI regulations on April 7, 2026. The certificate, issued by registrar KFin Technologies Limited, confirms proper reporting of securities transactions to stock exchanges. Company Secretary Yoshita Vora submitted the mandatory filing to BSE and NSE, ensuring regulatory compliance for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37143313

*this image is generated using AI for illustrative purposes only.

Viyash Scientific Limited has filed its quarterly compliance certificate with stock exchanges for the quarter ended March 31, 2026. The submission fulfills mandatory requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

Company Secretary and Compliance Officer Yoshita Vora submitted the certificate to both BSE Limited and National Stock Exchange of India Limited on April 7, 2026. The filing ensures adherence to securities market regulations governing depositories and participants.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 7, 2026
BSE Scrip Code: 512529
NSE Symbol: VIYASH
Regulation: SEBI (Depositories and Participants) Regulations, 2018

Registrar Confirmation

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate on April 6, 2026. Deputy Vice President Ganesh Chandra Patro confirmed that all required details of securities dematerialized and rematerialized during the quarter have been furnished to stock exchanges where the company's shares are listed.

Company Information

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, operates from its registered office in Hyderabad, Telangana. The company maintains its investor relations and corporate communications through established channels while ensuring regulatory compliance across all operational aspects.

Corporate Details: Information
Registered Office: Hyderabad, Telangana
CIN: L99999TS1985PLC196357
Registrar: KFin Technologies Limited
Contact: investorrelations@sequent.in

The quarterly compliance certificate represents standard regulatory practice, ensuring transparency in securities transactions and maintaining investor confidence through proper documentation and reporting procedures.

Historical Stock Returns for Viyash Scientific

1 Day5 Days1 Month6 Months1 Year5 Years
-2.30%-0.65%+15.00%+1.60%+39.11%-22.12%

What strategic changes might have prompted Sequent Scientific's rebranding to Viyash Scientific Limited?

How could the company's compliance track record impact its ability to raise capital or pursue acquisitions in 2026?

Will Viyash Scientific consider expanding its stock exchange listings beyond BSE and NSE to attract international investors?

Viyash Scientific Limited Allots 16,667 Equity Shares Under ESOP 2020 Scheme

1 min read     Updated on 03 Apr 2026, 12:50 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Viyash Scientific Limited allotted 16,667 equity shares under its ESOP 2020 scheme at Rs. 86 per share to eligible employees. The allotment, approved by the Nomination and Remuneration Committee on April 02, 2026, increased the company's paid-up capital from Rs. 87,37,01,620 to Rs. 87,37,34,954. The total equity shares outstanding rose from 43,68,50,810 to 43,68,67,477 shares of Rs. 2 each, with the new shares ranking pari passu with existing equity shares.

powered bylight_fuzz_icon
36703221

*this image is generated using AI for illustrative purposes only.

Viyash Scientific Limited has completed the allotment of equity shares under its employee stock option plan, marking another step in its employee incentive program. The company, formerly known as Sequent Scientific Limited, announced the allotment through a regulatory filing dated April 02, 2026.

ESOP Allotment Details

The Nomination and Remuneration Committee of Viyash Scientific Limited approved the allotment through a resolution passed by circulation on April 02, 2026. The allotment involved issuing shares to eligible employees under the SeQuent ESOP 2020 scheme.

Parameter: Details
Number of Shares Allotted: 16,667 equity shares
Face Value: Rs. 2 per share
Exercise Price: Rs. 86 per equity share
Scheme: SeQuent ESOP 2020
Status: Fully paid

Impact on Share Capital

The allotment has resulted in an increase in the company's issued and paid-up equity share capital. The newly allotted shares rank pari passu in all respects with the existing equity shares of the company.

Metric: Before Allotment After Allotment
Paid-up Capital: Rs. 87,37,01,620 Rs. 87,37,34,954
Number of Shares: 43,68,50,810 43,68,67,477
Face Value per Share: Rs. 2 Rs. 2

Corporate Information

Viyash Scientific Limited, formerly known as Sequent Scientific Limited, operates from its registered office in Hyderabad, Telangana. The company maintains its stock exchange listings and continues to use the symbol VIYASH for trading purposes. The allotment was communicated to both BSE Limited and National Stock Exchange of India Limited as part of regulatory compliance requirements.

The company secretary and compliance officer, Yoshita Vora, signed the regulatory filing digitally, ensuring proper documentation of the share allotment process. This ESOP allotment reflects the company's ongoing commitment to employee participation in its equity growth.

Historical Stock Returns for Viyash Scientific

1 Day5 Days1 Month6 Months1 Year5 Years
-2.30%-0.65%+15.00%+1.60%+39.11%-22.12%

Will Viyash Scientific expand its ESOP program further in 2026 to attract and retain talent in the competitive pharmaceutical sector?

How might the company's rebranding from Sequent Scientific to Viyash Scientific impact its market positioning and investor perception?

Could this ESOP allotment signal upcoming strategic initiatives or expansion plans that require enhanced employee commitment?

More News on Viyash Scientific

1 Year Returns:+39.11%